Several studies have indicated that alterations in CHRNA5 expression and/or activity are significantly related to lung cancer associated with smoking [25, 26], as well as various neurological disorders, such as Alzheimer's disease (AD) [27], Parkinson's disease [28], and schizophrenia [26]. Here, CHRNA5 is linked to Parkinson disease.